Literature DB >> 27453467

Multiple Origins of Virus Persistence during Natural Control of HIV Infection.

Eli A Boritz1, Samuel Darko1, Luke Swaszek1, Gideon Wolf1, David Wells2, Xiaolin Wu2, Amy R Henry1, Farida Laboune1, Jianfei Hu1, David Ambrozak3, Marybeth S Hughes4, Rebecca Hoh5, Joseph P Casazza3, Alexander Vostal3, Daniel Bunis1, Krystelle Nganou-Makamdop1, James S Lee1, Stephen A Migueles6, Richard A Koup3, Mark Connors6, Susan Moir6, Timothy Schacker7, Frank Maldarelli8, Stephen H Hughes8, Steven G Deeks5, Daniel C Douek9.   

Abstract

Targeted HIV cure strategies require definition of the mechanisms that maintain the virus. Here, we tracked HIV replication and the persistence of infected CD4 T cells in individuals with natural virologic control by sequencing viruses, T cell receptor genes, HIV integration sites, and cellular transcriptomes. Our results revealed three mechanisms of HIV persistence operating within distinct anatomic and functional compartments. In lymph node, we detected viruses with genetic and transcriptional attributes of active replication in both T follicular helper (TFH) cells and non-TFH memory cells. In blood, we detected inducible proviruses of archival origin among highly differentiated, clonally expanded cells. Linking the lymph node and blood was a small population of circulating cells harboring inducible proviruses of recent origin. Thus, HIV replication in lymphoid tissue, clonal expansion of infected cells, and recirculation of recently infected cells act together to maintain the virus in HIV controllers despite effective antiviral immunity. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27453467      PMCID: PMC4983216          DOI: 10.1016/j.cell.2016.06.039

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  41 in total

1.  Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

Authors:  Karen A O'Connell; Timothy P Brennan; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

2.  Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption.

Authors:  Meghan K Rothenberger; Brandon F Keele; Stephen W Wietgrefe; Courtney V Fletcher; Gregory J Beilman; Jeffrey G Chipman; Alexander Khoruts; Jacob D Estes; Jodi Anderson; Samuel P Callisto; Thomas E Schmidt; Ann Thorkelson; Cavan Reilly; Katherine Perkey; Thomas G Reimann; Netanya S Utay; Krystelle Nganou Makamdop; Mario Stevenson; Daniel C Douek; Ashley T Haase; Timothy W Schacker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

3.  A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.

Authors:  Adam M Spivak; Adriana Andrade; Evelyn Eisele; Rebecca Hoh; Peter Bacchetti; Namandjé N Bumpus; Fatemeh Emad; Robert Buckheit; Elinore F McCance-Katz; Jun Lai; Margene Kennedy; Geetanjali Chander; Robert F Siliciano; Janet D Siliciano; Steven G Deeks
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

4.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.

Authors:  Thomas A Rasmussen; Martin Tolstrup; Christel R Brinkmann; Rikke Olesen; Christian Erikstrup; Ajantha Solomon; Anni Winckelmann; Sarah Palmer; Charles Dinarello; Maria Buzon; Mathias Lichterfeld; Sharon R Lewin; Lars Østergaard; Ole S Søgaard
Journal:  Lancet HIV       Date:  2014-09-15       Impact factor: 12.767

6.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

7.  Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

Authors:  Tae-Wook Chun; J Shawn Justement; Danielle Murray; Connie J Kim; Jana Blazkova; Claire W Hallahan; Erika Benko; Cecilia T Costiniuk; Gabor Kandel; Mario Ostrowski; Rupert Kaul; Susan Moir; Joseph P Casazza; Richard A Koup; Colin Kovacs; Anthony S Fauci
Journal:  J Infect Dis       Date:  2013-07-11       Impact factor: 5.226

8.  Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.

Authors:  Maria Salgado; Timothy P Brennan; Karen A O'Connell; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  Retrovirology       Date:  2010-11-08       Impact factor: 4.602

9.  Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production.

Authors:  Matthieu Perreau; Anne-Laure Savoye; Elisa De Crignis; Jean-Marc Corpataux; Rafael Cubas; Elias K Haddad; Laurence De Leval; Cecilia Graziosi; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2012-12-17       Impact factor: 14.307

10.  Expression profile of host restriction factors in HIV-1 elite controllers.

Authors:  Mohamed Abdel-Mohsen; Rui André Saraiva Raposo; Xutao Deng; Manqing Li; Teri Liegler; Elizabeth Sinclair; Mohamed S Salama; Hussam El-Din A Ghanem; Rebecca Hoh; Joseph K Wong; Michael David; Douglas F Nixon; Steven G Deeks; Satish K Pillai
Journal:  Retrovirology       Date:  2013-10-16       Impact factor: 4.602

View more
  90 in total

Review 1.  Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.

Authors:  Rebecca Rose; David J Nolan; Ekaterina Maidji; Cheryl A Stoddart; Elyse J Singer; Susanna L Lamers; Michael S McGrath
Journal:  AIDS Res Hum Retroviruses       Date:  2017-08-07       Impact factor: 2.205

Review 2.  The mutable vaccine for mutable viruses.

Authors:  Marilia Cascalho; Samuel J Balin; Jeffrey L Platt
Journal:  Immunotherapy       Date:  2017-06       Impact factor: 4.196

3.  Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

Authors:  Rebecca T Veenhuis; Abena K Kwaa; Caroline C Garliss; Rachel Latanich; Maria Salgado; Christopher W Pohlmeyer; Christopher L Nobles; John Gregg; Eileen P Scully; Justin R Bailey; Frederic D Bushman; Joel N Blankson
Journal:  JCI Insight       Date:  2018-09-20

4.  Antibodies pose a double threat to HIV.

Authors:  Nancy L Haigwood
Journal:  Nature       Date:  2018-09       Impact factor: 49.962

5.  VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage.

Authors:  Chen-Hsiang Shen; Brandon J DeKosky; Yicheng Guo; Kai Xu; Ying Gu; Divya Kilam; Sung Hee Ko; Rui Kong; Kevin Liu; Mark K Louder; Li Ou; Baoshan Zhang; Cara W Chao; Martin M Corcoran; Eric Feng; Jesse Huang; Erica Normandin; Sijy O'Dell; Amy Ransier; Reda Rawi; Mallika Sastry; Stephen D Schmidt; Shuishu Wang; Yiran Wang; Gwo-Yu Chuang; Nicole A Doria-Rose; Bob Lin; Tongqing Zhou; Eli A Boritz; Mark Connors; Daniel C Douek; Gunilla B Karlsson Hedestam; Zizhang Sheng; Lawrence Shapiro; John R Mascola; Peter D Kwong
Journal:  Cell Host Microbe       Date:  2020-03-03       Impact factor: 21.023

Review 6.  Nuclear landscape of HIV-1 infection and integration.

Authors:  Marina Lusic; Robert F Siliciano
Journal:  Nat Rev Microbiol       Date:  2016-12-12       Impact factor: 60.633

7.  HIV enters deep sleep in people who naturally control the virus.

Authors:  Nicolas Chomont
Journal:  Nature       Date:  2020-09       Impact factor: 49.962

8.  Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.

Authors:  Ann J Hessell; Mariya B Shapiro; Rebecca Powell; Delphine C Malherbe; Sean P McBurney; Shilpi Pandey; Tracy Cheever; William F Sutton; Christoph Kahl; Byung Park; Susan Zolla-Pazner; Nancy L Haigwood
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.

Authors:  María Pernas; Laura Tarancón-Diez; Cecilio Lopez-Galindez; Ezequiel Ruiz-Mateos; Esther Rodríguez-Gallego; Josep Gómez; Julia G Prado; Concepción Casado; Beatriz Dominguez-Molina; Isabel Olivares; Maite Coiras; Agathe León; Carmen Rodriguez; Jose Miguel Benito; Norma Rallón; Montserrat Plana; Onofre Martinez-Madrid; Marta Dapena; Jose Antonio Iribarren; Jorge Del Romero; Felipe García; José Alcamí; MaÁngeles Muñoz-Fernández; Francisco Vidal; Manuel Leal
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

10.  Time course of cellular HIV-DNA and low-level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals.

Authors:  Saverio G Parisi; Samantha Andreis; Monica Basso; Silvia Cavinato; Renzo Scaggiante; Marzia Franzetti; Massimo Andreoni; Giorgio Palù; Anna Maria Cattelan
Journal:  Med Microbiol Immunol       Date:  2017-09-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.